Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5409 Target Snapshot

G-protein coupled bile acid receptor 1 · SINGLE PROTEIN · Homo sapiens

1,525Compounds
225Assays
12Approved Drugs
1,593.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8TDU6. Use UniProt Q8TDU6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8TDU6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats G-protein coupled bile acid receptor 1 as ChEMBL target CHEMBL5409, mapped to UniProt Q8TDU6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
G-protein coupled bile acid receptor 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5409
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8TDU6
G-protein coupled bile acid receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether G-protein coupled bile acid receptor 1 is the right protein anchor across sources, using UniProt Q8TDU6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelG-protein coupled bile acid receptor 1
UniProt AccessionQ8TDU6
Component TypeProtein
Sequence Length330 aa

G-protein coupled bile acid receptor 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as G-protein coupled bile acid receptor 1, mapped to UniProt Q8TDU6. Sequence length is 330 aa.

Mapped IDQ8TDU6
Review nameG-protein coupled bile acid receptor 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

12
Approved
3
Phase III
4
Phase II
3
Phase I
Assay Mix

Activity Type Distribution

IC5034.0
EC501,559.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3793436 10.24 EC50 0.057 Preclinical
CHEMBL2181247 9.64 EC50 0.23 Preclinical
CHEMBL3290717 9.55 EC50 0.28 Preclinical
CHEMBL2336232 9.52 EC50 0.3 Preclinical
CHEMBL2181229 9.51 EC50 0.31 Preclinical
CHEMBL4779837 9.48 EC50 0.33 Preclinical
CHEMBL5270816 9.37 EC50 0.43 Preclinical
CHEMBL3290716 9.35 EC50 0.45 Preclinical
CHEMBL2181227 9.34 EC50 0.46 Preclinical
CHEMBL2181228 9.22 EC50 0.6 Preclinical
Distribution

pChEMBL Value Distribution

131
5.0
182
5.5
266
6.0
245
6.5
201
7.0
154
7.5
71
8.0
41
8.5
14
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

OBETICHOLIC ACID
CHEMBL566315
Approved 2016
DEOXYCHOLIC ACID
CHEMBL406393
Approved 2015
PREDNISOLONE
CHEMBL131
Approved 1955
Assay Landscape

Assay Landscape

225
Total Assays
806
Tested Compounds
4
Assay Types
Functional — 164 assays, 806 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 152 785 6.5
assay format 10 20 7.1
single protein format 2 1 5.4
Binding — 55 assays, 418 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 30 79 7.3
single protein format 15 16 6.8
assay format 9 322 6.7
tissue-based format 1 1 6.6
Toxicity — 3 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 1 5.5
ADME — 3 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 2 3 6.4
cell-based format 1 3 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine